Leflunomide is a medication used in the management and treatment of rheumatoid arthritis. It is in the non-biological DMARDs class of medications. This activity reviews the indications, action, and contraindications for leflunomide as a valuable agent in treating and managing rheumatoid arthritis. This activity will highlight the mechanism of action, adverse event profile, and other key factors of leflunomide use in a clinical setting, pertinent to members of the interprofessional team in the care of patients with rheumatoid arthritis and related conditions.

**Objectives:**
- Identify the mechanism of action of leflunomide.
- Describe the potential adverse effects of leflunomide.
- Review the appropriate monitoring of leflunomide.
- Summarize some interprofessional team strategies for improving care coordination and communication to advance leflunomide use in the care of rheumatoid arthritis and improve outcomes.